Stereoselective Steroidal Reductions via Pyridine Solvents

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for synthesizing cholic acid derivatives are cumbersome and inefficient, particularly in achieving stereoselective reductions of double bonds in unsaturated intermediate compounds, which complicates the production of cholic acid derivatives like ursodeoxycholic acid and obeticholic acid.

Innovation Solution

The use of substituted pyridines as solvents in hydrogenation processes with Pd catalysts to selectively reduce the 4,5-double bond of 3-keto chol-4-enoic acids, resulting in high stereoselectivity for 5β products, such as ursodeoxycholic acid and tauroursodeoxycholic acid, by forming specific compounds like (5β,7β,20S)-7,21-dihydroxy-20-methyl-pregnan-3-one.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Manufacturing precision

If conventional hydrogenation methods are used to reduce double bonds in unsaturated intermediate compounds, then the reduction can be achieved, but the stereoselectivity is insufficient and requires additional chemical conversions and chromatographic purifications

Engineering Contradiction:
ImprovestereoselectivityVSAvoidprocess complexity
Core Design Contradiction:
Manufacturing precisionVSDevice complexity

Solution Approach 1:

The patent changes the solvent parameter from conventional solvents to pyridine-based solvents (pyridine, 3-picoline, 4-picoline) to achieve high stereoselectivity in the hydrogenation reaction. This parameter change enables preferential formation of 5β-products with >90% stereoselectivity, eliminating the need for additional purification steps and complex chromatographic separations.

Inventive Principle:
Principle #35Parameter changes

2Productivity

If multiple chemical conversions are used to achieve the desired steroid derivatives, then the synthesis can be completed, but the process becomes cumbersome and inefficient

Engineering Contradiction:
Improvesynthesis efficiencyVSAvoidprocess simplicity
Core Design Contradiction:
ProductivityVSEase of manufacture

Solution Approach 1:

The patent performs the hydrogenation reduction step under optimized conditions with pyridine solvents to achieve the desired stereoselectivity in a single step, preventing the need for subsequent chemical conversions and purifications. This preliminary action with optimized conditions streamlines the entire synthetic pathway and improves productivity.

Inventive Principle:
Principle #10Preliminary action

3Manufacturing precision

If conventional solvents are used in hydrogenation reactions, then the reaction can proceed, but the stereoselectivity is not sufficient for commercial utility

Engineering Contradiction:
ImprovestereoselectivityVSAvoidyield of desired isomer
Core Design Contradiction:
Manufacturing precisionVSQuantity of substance

Solution Approach 1:

The patent changes the solvent chemical environment from conventional solvents to pyridine-based solvents, which fundamentally alters the reaction stereoselectivity. This parameter change results in preferential formation of 5β-products with >90% stereoselectivity, significantly increasing the quantity of desired isomer and enabling commercial utility.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This method significantly enhances the efficiency and stereoselectivity of producing cholic acid derivatives, reducing the need for additional chemical conversions and chromatographic purifications, thereby streamlining the synthetic pathway.

Implementation Method 1

contacting the compound of Formula I with hydrogen in the presence of a Pd catalyst

Methodology Applied
Scientific EffectHydrogenation: Hydrogenation

Implementation Method 2

in the presence of a Pd catalyst

Methodology Applied
Scientific EffectCatalysis: Catalysis

Data Source

PatentUS20240425544A1Stereoselective steroidal reductions
Publication Date: 2024.12.26 SANDHILL ONE LLC
  • US20240425544A1 patent drawing
  • US20240425544A1 patent drawing
  • US20240425544A1 patent drawing

AI summary

Methods of making steroids, and to 5β stereoselective reductions of steroids to produce the same.